Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes
Abstract Δ9-Tetrahydrocannabivarin (THCV) is a cannabis-derived compound with unique properties that set it apart from the more common cannabinoids, such as Δ9-tetrahydrocannabinol (THC). The main advantage of THCV over THC is the lack of psychoactive effects. In rodent studies, THCV decreases appet...
Saved in:
Main Authors: | Amos Abioye (Author), Oladapo Ayodele (Author), Aleksandra Marinkovic (Author), Risha Patidar (Author), Adeola Akinwekomi (Author), Adekunle Sanyaolu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Measles Outbreak in Unvaccinated and Partially Vaccinated Children and Adults in the United States and Canada (2018-2019): A Narrative Review of Cases
by: Adekunle Sanyaolu, et al.
Published: (2019) -
Using In Silico Molecular Docking to Explain Differences in Receptor Binding Behavior of HHC and THCV Isomers: Revealing New Binding Modes
by: Mehdi Haghdoost, et al.
Published: (2024) -
Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review
by: Adekunle Sanyaolu, et al.
Published: (2022) -
The dimerization of Δ9-tetrahydrocannabinolic acid A (THCA-A)
by: Arben Cuadari, et al.
Published: (2019) -
Stigma, discrimination, and attitude towards the Chinese community in the USA and Canada during the outbreak of COVID-19
by: Adekunle Sanyaolu, et al.
Published: (2020)